193 related articles for article (PubMed ID: 16206166)
1. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
Chen SH; Gillespie GY; Benveniste EN
Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
[TBL] [Abstract][Full Text] [Related]
2. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
[TBL] [Abstract][Full Text] [Related]
4. The effects of oncostatin M on trophoblast cells: influence on matrix metalloproteinases-2 and -9, and invasion activity.
Ko HS; Kang HK; Kim HS; Choi SK; Park IY; Shin JC
Placenta; 2012 Nov; 33(11):908-13. PubMed ID: 22931588
[TBL] [Abstract][Full Text] [Related]
5. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J
J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
Repovic P; Fears CY; Gladson CL; Benveniste EN
Oncogene; 2003 Nov; 22(50):8117-24. PubMed ID: 14603252
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M signaling in human glioma cell lines.
Krona A; Järnum S; Salford LG; Widegren B; Aman P
Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.
Fearon U; Mullan R; Markham T; Connolly M; Sullivan S; Poole AR; FitzGerald O; Bresnihan B; Veale DJ
Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
12. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells.
Jorcyk CL; Holzer RG; Ryan RE
Cytokine; 2006 Mar; 33(6):323-36. PubMed ID: 16713283
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
15. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Loo WT; Chen JP; Chow LW; Chou JW
Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
[TBL] [Abstract][Full Text] [Related]
16. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity.
Chen MH; Cui SX; Cheng YN; Sun LR; Li QB; Xu WF; Ward SG; Tang W; Qu XJ
Anticancer Drugs; 2008 Nov; 19(10):957-65. PubMed ID: 18827560
[TBL] [Abstract][Full Text] [Related]
17. Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells.
Jung JS; Ahn JH; Le TK; Kim DH; Kim HS
Neurochem Int; 2013 Aug; 63(2):80-6. PubMed ID: 23684955
[TBL] [Abstract][Full Text] [Related]
18. Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells.
Kim SY; Jung SH; Kim HS
Biochem Biophys Res Commun; 2005 Nov; 337(2):510-6. PubMed ID: 16198311
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]